appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception HelixNano | Uses Nanotechnologies to Cure Genetic Diseases


Enterprise, Healthcare, Healthcare facilities & hospitals, Genetics, Biotechnology Cambridge, MA, United States

HelixNano

Artificial Intelligence | Machine Learning | Machine Perception


HelixNano | Uses Nanotechnologies to Cure Genetic Diseases

HelixNano

Healthcare, Healthcare facilities & hospitals, Genetics, Biotechnology


Cambridge, MA, United States

At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. 

HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge, our team is applying its expertise to deploy a novel vaccination approach against COVID-19.

 

B2C

1 to 25

Funded

$6,354,000

Scaling Up

2013

 
 

Healthcare
Health Care Facilities & Hospitals
Biotechnology

N/A

Cure Genetic Diseases, Fighting Cancer and COVID-19 With Synthetic Biology

 
 

N/A

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Novel Vaccination

Novel Vaccination


N/A

 

   Software


NA

NA


NA

NA

 
 
Hannu Rajaniemi


Hannu Rajaniemi
Co-Founder & CEO

Nikolai Eroshenko


Nikolai Eroshenko
Co-Founder and CSO